Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.12 | 0.7 |